Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer

Clinical trial NCT01945762 · COMPLETED

Trial details

NCT number: NCT01945762
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Symptomatic, Aggressive, Sporadic, Unresectable, Locally Advanced/Metastatic Medullary Thyroid Cancer (MTC)

Start date: 2014-02-17
Primary completion: 2020-06-18
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.